My Blog Posts will provide you my picks in realtime, no blah blah, just realtime trades. This way I have 100% credibility imo. I advise everyone to trust only people who post their calls in realtime.
Full time trading experience since early 1997 in Stocks Bonds Commodities Forex.
I am here only to help people take better financial decisions. I am not earning anything out of these calls. I am 40 yo.
H.B.Sc. from the University of Toronto specializing in Biology and Life Sciences, current Doctor of Optometry candidate studying at the University of Waterloo, started my own business in 2014 in the retail healthcare sector, and currently manage my own portfolio of investments while studying.
Got into investing because I love the research element of finding a special opportunity, and having real time feedback on whether the logic used was right. I have no formal education in this field, everything I know is from dozens of books, and hundreds of articles, interviews, and podcasts that I've read and listened to in the past few years. I look for asymmetric opportunities that provide quick option like gains on investment to bolster returns while holding other assets for long term growth. I'm open to further opportunities in this field, feel free to get in touch.
Lastly, I am young and learning every day, and acknowledge the likelihood that my opinions and strategies will develop and change as I gain further knowledge and experience in this field. Thus, this is a disclaimer that I am not a certified, registered, or accredited financial planner and/or investor, and material provided by me is my own opinion and purely for informational/entertainment purposes.
Cheers and thanks for visiting,
Be healthy, wealthy, happy, and savvy
I am now retired from the US pharma industry having spent over 33 years in the Mid-Atlantic corridor in Sales(Hospital mainly), Scientific Relations and Managed Care/LTC. I worked at BMY, Bayer/Miles Labs and SGP/MRK prior to early retirement..
Today I enjoy investing in Bio-Pharmas mostly, because it is what I know best!
I invest mostly in large companies such as BMY, PFE, MRK, GSK, and JNJ (love the divis) but I like the up and coming Bios like CLDX. Cancer and Immunotherapy intrigues me..so I have made that a major consideration since 2008....With BARDA,the GAIN act and QDIP Ive come to appreciate the Antibiotic cos.and have made them a major component of my LT strategy to build wealth while in Retirement....Ive invested in Trius(TSRX),CBST, CEMP, DRTX, TTPH, CTIX and just added AKAO.....
I manage personal monies and some family members..gratis of course!
With 30 years of investing experience, Strong Bio strives to identify highly undervalued biotechnology with clear publically disclosed scientific support in the form of peer reviewed journal articles or data analysis-driven open clinical studies.
Steven H. Goldman is a commercial litigation lawyer and senior partner in the Toronto law firm of Goldman Hine LLP. Steven graduated with a B.A., President's Medal recipient (1976, Carleton University, Ottawa, Ontario) and J.D. (1980, Queen's University, Kingston, Ontario). He is a former member of the board of directors of Tribute Pharmaceuticals Inc., a Canadian public pharmaceutical company which recently merged with Pozen Pharmaceuticals on February 5, 2016, and now known as Aralez Pharmaceuticals (Nasdaq: ARLZ), and a former member of the board of directors of Select Sands Corp. (TSX.Venture: SNS.V), having resigned from the board on December 21, 2016. He is currently a member of the board of directors of Comstock Metals Ltd. (TSX.V: CSL.V) which trade on the TSX Venture exchange, and member of the Executive of the Ontario Bar Association, Franchise Law Section. Steven was President & CEO of Speedy AutoService and Minute Muffer from December 2007 to December 31, 2009 (with approximately 160 locations across Canada).
I am a physician/entrepreneur, trader/investor who focuses on healthcare and biotech stocks. My investment strategy is seeking undervalued stocks with game changing products in their pipeline that will have a disruptive impact in the healthcare industry.
Learning as I go. My investing experience is limited, but I believe that biotechnology/pharmaceuticals hold the key to the best returns in the next 5-10 years. Targeted therapy, monoclonal antibodies, and genetic treatment tailoring are the future of medicine.
I am a practicing Army Physician (Diagnostic Radiologist). My professional interests include neuroradiology, brain tumors, head and neck cancer, functional MRI, and emerging tagged imaging agents. I intend to apply for a fellowship in neuroradiology this coming Summer. As such, I intend my writing to be speculative, but directed by science and my experiences thus far in medicine with an optimistic essence.
We look for potentially undervalued stocks in biotech, technology, and commodities sectors.
We perform research, and give investment opinions and ideas to buy-side firms from time to time.
We do not discuss unpublished reports, or provide any advanced warning of future reports to others.
We are not advisors.
As I'm a long-term investor, I'll highlight some stockpicks which will have a 5-7 year investment horizon. As I strongly believe a portfolio should consist of a mixture of dividend-paying stocks and growth stocks, my articles will reflect my thoughts on this mixture.
I am an individual investor who has been actively involved in the healthcare and biotechnology space for over 15 years. I hold a PhD in the biomedical sciences and have worked in both large pharmaceutical and small biotech companies. I make investments based on the fundamentals of a company and if I believe they have a superior technology or products compared to the competition. I'm an investor who believes patience pays off.
I have written 2 dutch books on value investing: "Aandelen selecteren als waardebelegger" and "Beleggen in bull- en bearmarkten". See bol.com (search for the titles). As a mathematician (Ph.D.) I am most interested in investment strategies with statistically favorable returns. In particular I invest in net-nets (20-30% average annual returns). I find companies with low Enterprise Value/Earnings before Tax and Interest (EV/EBIT) and strong balance sheets (20% average annual returns) also very interesting. Since such stocks are rare I invest globally. Send me a message with your email address to get example articles of my premium research on Seeking Alpha.
I am a value investor with a bent for quantitative analysis. I got my start as floor clerk as the CBOE. While I have moved on to other professional endeavors, I have retained my passion for markets. I became a SeekingAlpha contributor because the user and contributor bases are host to an immense diversity of opinions and talent sets.
Axioms to live by:
* "GAAP is crap". - Me
* "CAPM? More like CRAP-M!"
* "The Crapital Asset Pricing Novel" - Me
* "Post-Mortem Portfolio Theory " - Me
* "The WACC is whack! " (another knock on Modern Portfolio Theory) - Me
* "You have to understand the fundamentals first" - Aleks Chechkin
* "You want to know about charts? All ships at the bottom of the ocean had charts; look where that got 'em!" - Bill McMahon
* "If you spend more than 13 minutes analyzing economic and market forecasts, you've wasted 10 minutes." - Peter Lynch
* "The market can remain irrational for longer than you can remain solvent" - Keynes
* "The time to buy is when blood is in the streets" - Baron Rothschild
* "There is no such thing as a bad investment; just a bad price"
* "The solution for high (low) prices is high (low) prices"
* “You can’t compensate for risk by using a high discount rate.” - Warren Buffet, quoted at a 1998 Berkshire Hathaway shareholder meeting
* "It is better to be approximately right than precisely wrong" - Warren Buffett
* "There are two kinds of businesses: The first earns 12 percent, and you can take it out at the end of the year. The second earns 12 percent, but all the excess cash must be reinvested - there's never any cash. It reminds me of the guy who looks at all of his equipment and says, 'There's all of my profit.' We hate that kind of business." - Charlie Munger, Berkshire Hathaway 2013 Annual Meeting
* "You can observe a lot by just watching." - Yogi Berra
MD, MBA (Finance, NYU-Stern), certificate in financial modeling (Wharton). *Tipranks profile not accurate as doesn't pick up my premium ratings. Founder: Vasuda Healthcare Analytics (premium U.S. Biotech/pharma research) and Trident Asian Research (premium Asian investments research, www.tridentasia.com)
- Investment insights contributor: SumZero, Buy-side Institutional Platform (sumzero.com). Members of the platform include some of the largest hedge funds and asset managers.
-Former Insight Provider for Smartkarma Intelligent Investing (www.smartkarma.com): Institutional Investments Research Platform (was ranked among top 10 out of over 100 contributors). Clients included some of the largest hedge funds and asset managers.
- Buy-side equity research analyst covering mainly small-cap, emerging pharma/ biotech companies. M.D. with over 18 years of clinical experience (in the U.S. and India), still retaining full medical license in India. M.B.A. with finance and financial markets specialization from New York University Stern School of Business.
- Expert in picking healthcare-related investments, especially biotechnology and pharmaceuticals (focus on small, emerging companies). Investments are selected based on detailed due diligence, including proprietary DCF valuation models. Value investor with long-term horizon.
- Founder, managing principal of Vasuda Capital Management, healthcare-focused investment management firm, vasudacapitalmanagement.com. Registered Investment Advisor in Massachusetts.
- Also started and continue to sponsor Vasuda Global Orphan/ Rare disease biotechnology index, the first global equity index covering rare/orphan disease sector. Index quotes are available on bloomberg/reuters terminals.
Investment Banker. Chartered Accountant. Ex-Googler.
In his current avatar, Mihir works full-time with the investment banking team of an integrated financial services entity i.e. Ashika Group. He is based out of India's financial and entertainment capital Bombay and can be found hanging out with amazing people at phenomenal food joints. In love with creating interesting and insightful content, Mihir consistently prefers doing something he hasn't done before. A self-proclaimed fan of formula one racing, Elon Musk and his companies, everything tech, carefree lifestyle of Charlie Sheen and so on and so forth, he never runs out of topics to talk on. So, if you are looking to have an engaging conversation about anything under the sun, feel free to contact him on firstname.lastname@example.org
I am a high yield/distressed credit and deep value/reorg equity analyst. I have fundamental research and buy-side direct investing experience of 22 years in four continents, last 13 years of which were in US and 9 years in three emerging nations - India, Australia and Oman. My last job was with Dalton Investments LLC in Los Angeles, where I spent 13 years as Managing Director analyzing special situations, high yield/distressed credits, bank loans and reorg equities. As a generalist, I looked at more than 400 companies and gained knowledge in insolvency proceedings. By participating in creditor committees, I also gained expertise in corporate reorganization and rescue financing. Prior to Dalton, I worked at Al Ahlia Securities in Muscat, Oman, for more than two years as Head of Research for a $100 mn equity fund. Middle East and North African equities were key investing targets. Prior to Al Ahlia, I worked as Head of Research at ANZ Investment Bank for two years in Syndey, Australia and Mumbai, India. While setting up an Indian asset management company for Australian bank ANZ, I gained research experience in Australian mining, minerals, telecom and tourism sectors. Prior to ANZ, I worked at Unit Trust of India, Indias largest mutual fund at that time, between March 1992 and December 1996. I personally visited more than 300 companies in various parts of India and analyzed/invested in their debt/equity. I hold an MBA from Marshall School of Business, University of Southern California. I also hold an MBA from Indian Institute of Management, Ahmedabad IIM-A. I hold a B.Tech in Aerospace Engineering from Indian Institute of Technology, Kharagpur IIT-KGP. I am Chartered Financial Analyst CFA and a member of CFA Institute/CFA society of Los Angeles.
Engineer by trade and passion. Have worked internationally for over three decades, running my own business. I hold a PhD in engineering, but honestly believe that the school of hard knocks has taught me lessons that are more applicable to my writing here on Seeking Alpha. My investing interests mostly concern the resource sector, with a focus on precious metals, base metals and energy stocks of all sizes. My research explicitly includes small- and micro-cap juniors, and I try to manage the associated risks in a methodical manner.
I'm a CFA Charterholder and hold an MBA in Finance.
I spend a large amount of my free time analyzing and investing in energy companies of varying size. I'm currently covering oil and gas producers in the Permian Basin and the Eagle Ford. I try to provide quarterly coverage for several companies. I also look at oil and gas producers globally, in search of strong value plays. Anytime I find one, I write about it.
I will do my absolute best to provide quality research for you to consider in your investment decisions. However, I suggest you consult with your financial advisor prior to taking any action after reading an article, comment, private chat, or any other communication that I wrote. I urge you do your own research and draw your own conclusions prior to taking any action. My articles or comments are your starting point for your research. After you enter a trade, you are on your own to enter, exit, or take no action on the trade. I am not liable for actions you take after reading something that I wrote.
I am a high school teacher for a decade.
Before that I was an analyst (operations and financial) and for a short time a Controller
I have a B.S. with an emphasis in Accounting and an MBA (for which I studied Finance, Economics, and Management)
I passed the CPA exam on the first try and am a retired CPA in the state of Maryland.
I have a high school teaching credential and an MA in Math Education
I have more than 10 years experience investing in commodities and hard assets such as gold and silver miners, exploration companies, oil and gas producers, MLPs, and various other sectors.
Have been investing for myself and my family for over 50 years. Retired sociology professor who also started and sold 3 retail stores over my career in teaching. Since I am retired, i am looking for stocks that pay dividends and offer some growth to keep up with inflation.
I am a reformed and recovering management consultant who, through multiple client engagements, applies deep exposure to the upstream and midstream oil and gas industry to create a picture of where these businesses will be in the next two years. With a background in both engineering and finance, I approach investing through a quantitative value approach for the medium and long term horizon.
The investment return profile looks to generate anywhere between 25 and 250 percent within a 12 to 36 month window and minimizes risk by focusing on businesses whose equity is liquid, and are large enough to allow a significant placement of investment assets (generally businesses with total enterprise values in excess of $250mm). The key elements of my investment style are:
1. Is there even the slightest chance the company is going bankrupt? If not, I just stop. I want stuff I can hang on to for long periods without significant risk.
2. Are the managers real artisans in their fields or have they fallen prey to the two most common corporate diseases: (a) their professional management activities are more important that the growth of the company or (b) their skills as financial engineers building masterpieces of leverage are more interesting to them than running a boring business. If not, I just stop. I want people running my investment that I can trust. Included in this category is skin in the game… they better own some measurable percentage of the business so that their own personal fortunes are tied up in it.
3. Is the business they are in one I could explain in under 30 minutes to my 10 year old son? For example, they suck natural gas out of the ground and sell it to whomever will give them the most for it. If not, I just stop. I want stuff I can understand without twisting my brain into a pretzel.
4. Do they build and/or sell stuff that during times of economic recession are truly discretionary items? If they are, I just stop. I want stuff that makes/sells things people need rain or shine.
Fundamentally, I believe self-directed investors can use their own experience and powers of understanding to make exceptional investments on their own, without turning to the professional investment advisory community... and obtain a much better return profile on their assets in the process. I like discovering value, whether because of cyclical down-on-hard-luck stories or secular growth stories and highlighting why I believe they are so.
Patience, low investment position turnover, true understanding of real value of a business, and the power of geometric compounding are the things for which I strive.
I am a Junior Structural Engineer located in Montreal. I completed my Master’s Degree of Structural Engineering in December 2015 with a 3.60/4.00 GPA. I focus on Canadian equities. Long only.
After a trial period writing for SA, it appears that the editorial policies favour short-term view articles with little relevance with the valuation of the company. To maximise my gains, I would have to write shorter non relevant articles. I am not going to do that, so I guess this is goodbye.
Well, that was fun while it lasted !
I have worked in corporate finance for three Fortune 500 companies including those in the Oil and Gas, Building Materials, and Retail sectors. Most recently I moved to California to work for a multi-billion tech company in Silicon Valley. I will never write articles about the company I am currently working for due to the sensitivity of the information I deal with everyday.
- Masters Finance
- Previous work at Boutique Investment Bank, Bulge Bracket, and Commercial Bank
Taken Graduate Level courses in Financial Modeling, Financial Econometrics, Fixed Income Investments (MBS/CMBS/Bonds, Interest Rate Derivatives), Derivatives (Calls, Puts, Spreads, Futures, Forwards, Swaps, and Exotic Options), Portfolio Management (DCF modeling), Mergers and Acquisition, and Macroeconomics.
I provide economic analysis, market commentary and company-specific research. My general view is to operate a diversified basket of long-term investments in both equities and fixed income. I have a bachelor's degree in economics from San Diego State University (2007), eight years of publishing experience and over a decade of cumulative investment experience. I have been published in several newspapers and magazines, including The Wall Street Journal and Barron's.
I am a devotee of technology, data and education. I seek deep understanding in everything I do. I have studied sciences, computing, and quants. I apply a voracious appetite for knowledge to both my professional and financial life.
Employed in the tech industry for 30 years in development, IT management, product management and business consulting. Investing style is Under-Valued and Value-based. Margin of Safety is my friend. Graham, Fisher and Buffet are my investing heroes.